Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- V
- W
- X
- Y
- Z
- І
- А
- Б
- В
- Г
- Д
- Е
- Ж
- З
- И
- К
- Л
- М
- Н
- О
- П
- Р
- С
- Т
- У
- Ф
- Х
- Ц
- Ч
- Ш
- Щ
- Э
- Ю
- Я
- Весь список
Warning: mb_strpos(): Empty delimiter in /var/www/u1363561/data/www/biotech.spb.ru/wp-content/plugins/code-snippets/php/snippet-ops.php(581) : eval()’d code(4) : eval()’d code on line 13
L Bergmann, K Fenchel, E Weidmann, H M Enzinger, B Jahn, D Jonas, P S Mitrou
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II studyCancer. 1993 Sep 1;72(5):1733-42.
Ladenstein R1, Pötschger U, Siabalis D et al.
Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion.J Clin Oncol. 2011 Feb 1;29(4):441-8. doi: 10.1200/JCO.2009.23.5465.
Lafreniere R, Rosenberg SA.
Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.Cancer Res. 1985 Aug;45(8):3735-41. PMID: 3893689.
Lafreniere R, Rosenberg SA.
Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma.J Immunol. 1985 Dec;135(6):4273-80. PMID: 3877766.
Laura Elisa Buitrago-Molina, Julia Pietrek, Fatih Noyan et al. 
PDF
Journal of Autoimmunity. – 2021. — Volume 117, February 2021, 102591
Laurence B Peterson, Charles J M Bell, Sarah K Howlett, Marcin L Pekalski, Kevin Brady, Heather Hinton, Denise Sauter, John A Todd, Pablo Umana, Oliver Ast, Inja Waldhauer, Anne Freimoser-Grundschober, Ekkehard Moessner, Christian Klein, Ralf J Hosse, Lin
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseJ Autoimmun. 2018 Dec;95:1-14.
Lavrenova G., Katinas E., Galkina O. et al.
Local use of recombinant human Interleukin-2 in treatment of purulent sinusitis.
Int. J. Immunorehabilitation. 2000. V. 2. № 3. P. 114.
Le Xu, Xiaolei Song, Lili Su et al. PDF
International Immunopharmacology. — 2019. — Vol. 72, P. 322-329.
Lei J, Guan B, Li B et al.
Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.Protein Expr Purif. 2012 Jul;84(1):154-60.
Levashov P.A., Matolygina D.A., Ovchinnikova E.D. et al. PDF
Acta Naturae. 2017 Apr-Jun;9(2):82-87. PMID: 28740730; PMCID: PMC5509004.
Levashov P.A., Ovchinnikova E.D., Morozova O.A. et al.
Human Interleukin-2 and Hen Egg White Lysozyme: Screening for Bacteriolytic Activity against Various Bacterial Cells.Acta Naturae. 2016 Jan-Mar;8(1):98-102. PMID: 27099789; PMCID: PMC4837576.
Levashov P.A., Sedov S.A.,Belogurova N.G., Shipovskov N.G., Levashov A.V.
Bacteriolytic activity of human interleukin-2.Biochemistry (Mosc). 2012 Nov;77(11):1312-4. doi: 10.1134/S0006297912110107.
Li J, Zhang Z, Du S, Guo Q.
Interleukin 2 Ameliorates Autoimmune Neuroinflammation by Modulating the Balance of T Helper 17 Cells and Regulatory T Cells in Mouse.Ann Clin Lab Sci. 2021 Jul;51(4):529-534. PMID: 34452891.
Linlin Shi, Jianyong Sheng, Guozhong Chen et al. PDF
J Immunother Cancer. — 2020. — P. 1-14.
Lipatova L., N.B. Serebryanaya, N. Sivakova, T. Kapustina
Experience of using rIL-2h cytokine therapy in epilepsy.
VIII Word Asthma, Allergy and COPD Forum and XXI World congress on rehabilitation in medicine and immunorehabilitation: Allergy, Asthma and Immunophysiology: recent advances in understanding and management. Singapore, 2015. Medimond — International Procee
Litvinova L.S., Sokhonevich N.A., Gutsol A.A., Kofanova K.A.
Influence of Immunoregulatory Cytokines (IL-2, IL-7 and IL-15) in Vitro Upon Activation, Proliferation and Apoptosis of Immune Memory T-cells.Tsitologiia 2013; 55(8):566-71.
Lopes de Menezes, Denis-Mize K, Tang Y et al.
Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.Journal of Immunotherapy. 2007 Jan;30(1):64-74.
ZIP ClinicalTrials.gov. 2020.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.